Literature DB >> 9950823

Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats.

B Qiu1, C Pothoulakis, I Castagliuolo, S Nikulasson, J T LaMont.   

Abstract

Reactive oxygen metabolites (ROMs) contribute to the pathophysiology of intestinal inflammation. Our aim was to ascertain the involvement of ROMs in experimental ileitis in rats produced by toxin A of Clostridium difficile. Intraluminal toxin A caused a significant increase in hydroxyl radical and hydrogen peroxide production by ileal microsomes starting 1 h following toxin exposure and peaking at 2-3 h, and this was inhibited by pretreatment with DMSO, a ROM scavenger, or superoxide dismutase (SOD), which inactivates ROMs. In contrast, mucosal xanthine oxidase increased only slightly after toxin A exposure, and allopurinol, an inhibitor of xanthine oxidase, had no effect on toxin A-associated intestinal responses. Induction of neutropenia resulted in reduction of toxin-mediated free radical formation, fluid secretion, and permeability. The enterotoxic effects of C. difficile toxin A were associated with increased ROM release in ileal tissues, and the ROM inhibitors DMSO and SOD inhibited these effects. This suggests that ROMs released during toxin A enteritis are released primarily from neutrophils invading the inflamed bowel segment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950823     DOI: 10.1152/ajpgi.1999.276.2.G485

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

4.  Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects.

Authors:  Gerly A C Brito; Benedito Carneiro-Filho; Reinaldo B Oriá; Raul V Destura; Aldo A M Lima; Richard L Guerrant
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 5.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 6.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

7.  Effects of nitric oxide on gastric ulceration induced by nicotine and cold-restraint stress.

Authors:  Bo-Sheng Qui; Qi-Bing Mei; Li Liu; Kam-Meng Tchou-Wong
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

8.  Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation.

Authors:  Pauline M Anton; Jerome Gay; Andreas Mykoniatis; Amy Pan; Michael O'Brien; Daniel Brown; Katia Karalis; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

9.  Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex.

Authors:  Melissa A Farrow; Nicole M Chumbler; Lynne A Lapierre; Jeffrey L Franklin; Stacey A Rutherford; James R Goldenring; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

10.  Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis.

Authors:  Rajat Madan; Xiaoti Guo; Caitlin Naylor; Erica L Buonomo; Donald Mackay; Zannatun Noor; Patrick Concannon; Kenneth W Scully; Patcharin Pramoonjago; Glynis L Kolling; Cirle A Warren; Priya Duggal; William A Petri
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.